Kelei Li

No. 35 Simiao Road
Daxing, 102629, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

An intramuscular prime-intranasal boost strategy for mRNA-LNP vaccine induces mucosal immune response against SARS-CoV-2 in murine model.

An intramuscular prime-intranasal boost strategy for mRNA-LNP vaccine induces mucosal immune response against SARS-CoV-2 in murine model.

Journal: Journal of translational medicine
Published: November 11, 2025

Optimization of In Vitro Transcription by Design of Experiment to Achieve High Self-Amplifying RNA Integrity.

Optimization of In Vitro Transcription by Design of Experiment to Achieve High Self-Amplifying RNA Integrity.

Journal: Vaccines
Published: September 14, 2025

Fabrication and Properties of Zn-Containing Intermetallic Compounds as Sacrificial Anodes of Zn-Based Implants.

Fabrication and Properties of Zn-Containing Intermetallic Compounds as Sacrificial Anodes of Zn-Based Implants.

Journal: Materials (Basel, Switzerland)
Published: March 28, 2025

An attenuated coxsackievirus B5 mutant carrying VP1-N157K retains oncolytic potency against non-small cell lung cancer.

An attenuated coxsackievirus B5 mutant carrying VP1-N157K retains oncolytic potency against non-small cell lung cancer.

Journal: Molecular therapy. Oncology
Published: November 07, 2024

A Novel Targeted RIG-I Receptor 5'Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine.

A Novel Targeted RIG-I Receptor 5'Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine.

Journal: Viruses
Published: April 11, 2023

Comparison of the immunogenicity of nasal-spray rVSV vector, adenovirus vector, and inactivated COVID-19-based vaccines in rodent models.

Comparison of the immunogenicity of nasal-spray rVSV vector, adenovirus vector, and inactivated COVID-19-based vaccines in rodent models.

Journal: Journal of medical virology
Published: February 23, 2023

Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors.

Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors.

Journal: Signal transduction and targeted therapy
Published: January 10, 2023

CpG 684: an effective adjuvant for the inactivated COVID-19 vaccine in mice.

CpG 684: an effective adjuvant for the inactivated COVID-19 vaccine in mice.

Journal: Future virology
Published: September 08, 2022

A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine.

A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine.

Journal: Viruses
Published: June 27, 2022

Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10.

Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10.

Journal: Human vaccines & immunotherapeutics
Published: December 19, 2019

Effect of freezing on recombinant hepatitis E vaccine.

Effect of freezing on recombinant hepatitis E vaccine.

Journal: Human vaccines & immunotherapeutics
Published: December 07, 2019

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge.

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge.

Journal: Human vaccines & immunotherapeutics
Published: February 09, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026